AtriCure, Inc.
ATRC
$29.94
$0.411.39%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.64% | -1.37% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.64% | -1.37% | |||
| Cost of Revenue | 6.76% | -4.96% | |||
| Gross Profit | 3.95% | -0.15% | |||
| SG&A Expenses | 0.14% | -0.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 2.94% | -5.81% | |||
| Operating Income | 1,097.60% | 103.36% | |||
| Income Before Tax | 2,844.19% | 98.55% | |||
| Income Tax Expenses | 233.70% | -30.65% | |||
| Earnings from Continuing Operations | 757.68% | 95.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 757.68% | 95.69% | |||
| EBIT | 1,097.60% | 103.36% | |||
| EBITDA | 41.31% | 626.64% | |||
| EPS Basic | 753.57% | 95.68% | |||
| Normalized Basic EPS | 2,900.00% | 98.58% | |||
| EPS Diluted | 741.07% | 95.68% | |||
| Normalized Diluted EPS | 2,845.45% | 98.58% | |||
| Average Basic Shares Outstanding | 0.08% | 0.42% | |||
| Average Diluted Shares Outstanding | 1.99% | 0.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||